Device Heart Valves

Hancock II

Payments companies reported to CMS as associated with Hancock II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,594associated payments (2023-2025)
17clinicians with associated payments
1company reporting

By year

2023 $1,880
2024 $713

Payments reported as associated with Hancock II, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,807
Acute Care (Nurse Practitioner) $197
Anatomic Pathology & Clinical Pathology $197
Surgical $197
Physician Assistant $141
Anesthesiology $39.45

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hancock II

These are the largest totals companies reported as associated with Hancock II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Ciccolo Las Vegas, NV Thoracic Surgery (Cardiothoracic Vascular Surgery) $362.72
Sunjay Kaushal Las Vegas, NV Thoracic Surgery (Cardiothoracic Vascular Surgery) $323.25
Rachel Hargrove Fountain Valley, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $202.07
Tuan Lam Fountain Valley, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $202.06
Richard Chiu Sacramento, CA Anatomic Pathology & Clinical Pathology $197.24
Jennifer Kirk Long Beach, CA Acute Care (Nurse Practitioner) $197.24
Marc Sakwa Long Beach, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $197.24
Crystal Rene De Cotret Long Beach, CA Surgical $197.23
Saad Hasan Cincinnati, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $169.51
Sebastian Pagni Louisville, KY Thoracic Surgery (Cardiothoracic Vascular Surgery) $169.51

Prescribed Hancock II?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.